FDA Drug Application (202922) for OXALIPLATIN by SUN PHARMA GLOBAL

Back to FDA Applications sponsored by SUN PHARMA GLOBAL

Application Number202922
Product Number001
FormINJECTABLE;IV (INFUSION)
Dosage50MG/10ML (5MG/ML)
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code AP Injectable aqueous solutions and, in certain instances, intravenous non-aqueous solutions
Reference Drug
Drug NameOXALIPLATIN
Active IngredientOXALIPLATIN



Back to FDA Applications sponsored by SUN PHARMA GLOBAL

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.